checkAd
    Startseite > Aktien > AC Immune > Nachrichten
    AC Immune Aktie
    4,2650
     
    EUR
    +16,53 %
    +0,6050 EUR
    Letzter Kurs 31.05.24 Tradegate
    4,1700
     
    EUR
    1.500 STK
    Geldkurs 31.05.24
    4,3550
     
    EUR
    1.500 STK
    Briefkurs 31.05.24
    ISIN: CH0329023102 · WKN: A2AR5F · SYM: IMR · Schweiz

    Neueste Nachrichten

    AC Immune to Present at the Jefferies Global Healthcare Conference in June 2024
    28.05.24 · globenewswire · AC Immune
    Fokus Aktien mit extremen Handelsvolumen am Montag, den 13.05.2024
    13.05.24 · wO Chartvergleich · ArcticZymes Technologies
    AC Immune Reports First Quarter 2024 Financial Results and Provides a Corporate Update
    13.05.24 · globenewswire · AC Immune
    AC Immune and Takeda Sign Exclusive Option and License Agreement for Active Immunotherapy Targeting Amyloid Beta for Alzheimer’s Disease
    13.05.24 · Business Wire (engl.) · Takeda Yakuhin Kogyo
    AC Immune and Takeda Sign Exclusive Option and License Agreement for Active Immunotherapy Targeting Amyloid Beta for Alzheimer’s Disease
    13.05.24 · globenewswire · AC Immune
    AC Immune Reports Full Year 2023 Financial Results and Provides a Corporate Update
    14.03.24 · globenewswire · AC Immune
    AC Immune Announces Upcoming Presentations at AD/PD 2024
    22.02.24 · globenewswire · AC Immune
    AC Immune to Regain Global Rights to Crenezumab and Semorinemab
    22.01.24 · globenewswire · AC Immune
    AC Immune Progress Update on Phase 2 Active Immunotherapy Clinical Pipeline for Alzheimer's and Parkinson diseases
    03.01.24 · globenewswire · AC Immune
    AC Immune Announces Pricing of Underwritten Offering of Common Shares
    15.12.23 · globenewswire · AC Immune
    AC Immune’s Targeted Anti-pTau Active Immunotherapy for Alzheimer’s Disease Advances into Phase 2b Trial
    15.12.23 · globenewswire · AC Immune
    AC Immune to Present at the Jefferies 2023 London Healthcare Conference
    07.11.23 · globenewswire · AC Immune